Skip to content

OMTHERA PHARMACEUTICALS, INC.

CIK 0001477598

← back to feed
Revenue (TTM)
—
Q1 May 2013
Net Income (TTM)
—
Q1 May 2013
EPS Diluted (TTM)
—
Q1 May 2013
Gross Margin
—
Q1 May 2013
Operating Margin
—
Q1 May 2013
Net Margin
—
Q1 May 2013
Free Cash Flow (TTM)
—
Q1 May 2013
Cash
$14.42M
Q1 May 2013
Total Debt
—
Q1 May 2013
Shares Outstanding
24.41M sh
Q1 May 2013

Recent filings